Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Parker-Hannifin
PH
|
+$296M |
| 2 |
Microsoft
MSFT
|
+$279M |
| 3 |
Union Pacific
UNP
|
+$267M |
| 4 |
LLL
L3 Technologies, Inc.
LLL
|
+$259M |
| 5 |
McDonald's
MCD
|
+$254M |
Top Sells
| 1 |
Medtronic
MDT
|
+$592M |
| 2 |
Apple
AAPL
|
+$523M |
| 3 |
Amgen
AMGN
|
+$457M |
| 4 |
General Dynamics
GD
|
+$401M |
| 5 |
CSX Corp
CSX
|
+$338M |
Sector Composition
| 1 | Technology | 23.95% |
| 2 | Healthcare | 14.99% |
| 3 | Financials | 13.93% |
| 4 | Industrials | 13.17% |
| 5 | Consumer Discretionary | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
776
Ingles Markets
IMKTA
$1.3B
| $21.9M | 0.01% |
646,531
| – | – |
|
777
Rhythm Pharmaceuticals
RYTM
$6.65B
| $21.8M | 0.01% |
1,094,620
+339,460
| +45% | +$6.76M |
|
|
CBM
778
DELISTED
Cambrex Corporation
CBM
| $21.7M | 0.01% |
415,816
+152,316
| +58% | +$7.97M |
|
|
DEA
779
Easterly Government Properties
DEA
$1.04B
| $21.7M | 0.01% |
424,687
-6,631
| -2% | -$338K |
|
|
LXFT
780
DELISTED
Luxoft Holding, Inc.
LXFT
| $21.6M | 0.01% |
527,593
+498,252
| +1,698% | +$20.4M |
|
781
Alcoa
AA
$8.25B
| $21.4M | 0.01% |
476,810
+72,140
| +18% | +$3.24M |
|
782
Acuity Brands
AYI
$10.2B
| $21.2M | 0.01% |
152,226
-77,765
| -34% | -$10.8M |
|
783
iShares Preferred and Income Securities ETF
PFF
$14.6B
| $21.2M | 0.01% |
563,365
-55,000
| -9% | -$2.07M |
|
784
ResMed
RMD
$39.8B
| $21.1M | 0.01% |
214,363
-47,957
| -18% | -$4.72M |
|
785
HP
HPQ
$26.6B
| $21.1M | 0.01% |
961,658
-5,498,654
| -85% | -$121M |
|
786
Danaher
DHR
$140B
| $21M | 0.01% |
241,737
-24,120
| -9% | -$2.09M |
|
787
New Oriental
EDU
$8.69B
| $20.7M | 0.01% |
236,413
-45,900
| -16% | -$4.02M |
|
|
ECOM
788
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $20.5M | 0.01% |
2,255,469
-7,120
| -0.3% | -$64.8K |
|
789
Jefferies Financial Group
JEF
$13.4B
| $20.5M | 0.01% |
1,005,102
-699,918
| -41% | -$14.2M |
|
790
Willis Towers Watson
WTW
$32.2B
| $20.1M | 0.01% |
132,015
+20,249
| +18% | +$3.08M |
|
|
TWO
791
Two Harbors Investment
TWO
$1.07B
| $19.9M | 0.01% |
324,298
-361,801
| -53% | -$22.2M |
|
792
Sanofi
SNY
$114B
| $19.9M | 0.01% |
497,421
-6,726
| -1% | -$270K |
|
793
Freeport-McMoran
FCX
$64.2B
| $19.9M | 0.01% |
1,131,489
+664,892
| +142% | +$11.7M |
|
794
MGM Resorts International
MGM
$9.82B
| $19.6M | 0.01% |
560,933
-209,457
| -27% | -$7.34M |
|
|
CBIO
795
Crescent Biopharma, Inc. Common Stock
CBIO
$168M
| $19.6M | 0.01% |
12,070
+2,292
| +23% | +$3.72M |
|
796
HealthStream
HSTM
$846M
| $19.3M | 0.01% |
779,227
-78,933
| -9% | -$1.96M |
|
797
Invesco QQQ Trust
QQQ
$370B
| $19.3M | 0.01% |
120,829
-28,726
| -19% | -$4.6M |
|
798
Tactile Systems Technology
TCMD
$299M
| $19M | 0.01% |
+597,149
| New | +$19M |
|
799
Target
TGT
$41.4B
| $19M | 0.01% |
273,693
+14,802
| +6% | +$1.03M |
|
800
Mohawk Industries
MHK
$8.37B
| $19M | 0.01% |
81,632
+34,300
| +72% | +$7.97M |
|